Global Expectorant Drug Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Expectorant Drug Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Expectorant Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Oral Solid
  • 1.2.3 Oral Liquid
  • 1.2.4 Inhalants
• 1.3 Market by Application
  • 1.3.1 Global Expectorant Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Expectorant Drug Sales Estimates and Forecasts 2019-2030
• 2.2 Global Expectorant Drug Revenue by Region
  • 2.2.1 Global Expectorant Drug Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Expectorant Drug Revenue by Region (2019-2024)
  • 2.2.3 Global Expectorant Drug Revenue by Region (2025-2030)
  • 2.2.4 Global Expectorant Drug Revenue Market Share by Region (2019-2030)
• 2.3 Global Expectorant Drug Sales Estimates and Forecasts 2019-2030
• 2.4 Global Expectorant Drug Sales by Region
  • 2.4.1 Global Expectorant Drug Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Expectorant Drug Sales by Region (2019-2024)
  • 2.4.3 Global Expectorant Drug Sales by Region (2025-2030)
  • 2.4.4 Global Expectorant Drug Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global Expectorant Drug Sales by Manufacturers
  • 3.1.1 Global Expectorant Drug Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Expectorant Drug Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Expectorant Drug in 2023
• 3.2 Global Expectorant Drug Revenue by Manufacturers
  • 3.2.1 Global Expectorant Drug Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Expectorant Drug Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Expectorant Drug Revenue in 2023
• 3.3 Global Key Players of Expectorant Drug, Industry Ranking, 2022 VS 2023 VS 2024
• 3.4 Global Expectorant Drug Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Expectorant Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Expectorant Drug, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Expectorant Drug, Product Offered and Application
• 3.8 Global Key Manufacturers of Expectorant Drug, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Expectorant Drug Sales by Type
  • 4.1.1 Global Expectorant Drug Historical Sales by Type (2019-2024)
  • 4.1.2 Global Expectorant Drug Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Expectorant Drug Sales Market Share by Type (2019-2030)
• 4.2 Global Expectorant Drug Revenue by Type
  • 4.2.1 Global Expectorant Drug Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Expectorant Drug Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Expectorant Drug Revenue Market Share by Type (2019-2030)
• 4.3 Global Expectorant Drug Price by Type
  • 4.3.1 Global Expectorant Drug Price by Type (2019-2024)
  • 4.3.2 Global Expectorant Drug Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Expectorant Drug Sales by Application
  • 5.1.1 Global Expectorant Drug Historical Sales by Application (2019-2024)
  • 5.1.2 Global Expectorant Drug Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Expectorant Drug Sales Market Share by Application (2019-2030)
• 5.2 Global Expectorant Drug Revenue by Application
  • 5.2.1 Global Expectorant Drug Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Expectorant Drug Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Expectorant Drug Revenue Market Share by Application (2019-2030)
• 5.3 Global Expectorant Drug Price by Application
  • 5.3.1 Global Expectorant Drug Price by Application (2019-2024)
  • 5.3.2 Global Expectorant Drug Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Expectorant Drug Market Size by Type
  • 6.1.1 US & Canada Expectorant Drug Sales by Type (2019-2030)
  • 6.1.2 US & Canada Expectorant Drug Revenue by Type (2019-2030)
• 6.2 US & Canada Expectorant Drug Market Size by Application
  • 6.2.1 US & Canada Expectorant Drug Sales by Application (2019-2030)
  • 6.2.2 US & Canada Expectorant Drug Revenue by Application (2019-2030)
• 6.3 US & Canada Expectorant Drug Market Size by Country
  • 6.3.1 US & Canada Expectorant Drug Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Expectorant Drug Sales by Country (2019-2030)
  • 6.3.3 US & Canada Expectorant Drug Revenue by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Expectorant Drug Market Size by Type
  • 7.1.1 Europe Expectorant Drug Sales by Type (2019-2030)
  • 7.1.2 Europe Expectorant Drug Revenue by Type (2019-2030)
• 7.2 Europe Expectorant Drug Market Size by Application
  • 7.2.1 Europe Expectorant Drug Sales by Application (2019-2030)
  • 7.2.2 Europe Expectorant Drug Revenue by Application (2019-2030)
• 7.3 Europe Expectorant Drug Market Size by Country
  • 7.3.1 Europe Expectorant Drug Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Expectorant Drug Sales by Country (2019-2030)
  • 7.3.3 Europe Expectorant Drug Revenue by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Netherlands

8 China

• 8.1 China Expectorant Drug Market Size
  • 8.1.1 China Expectorant Drug Sales (2019-2030)
  • 8.1.2 China Expectorant Drug Revenue (2019-2030)
• 8.2 China Expectorant Drug Market Size by Application
  • 8.2.1 China Expectorant Drug Sales by Application (2019-2030)
  • 8.2.2 China Expectorant Drug Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Expectorant Drug Market Size by Type
  • 9.1.1 Asia Expectorant Drug Sales by Type (2019-2030)
  • 9.1.2 Asia Expectorant Drug Revenue by Type (2019-2030)
• 9.2 Asia Expectorant Drug Market Size by Application
  • 9.2.1 Asia Expectorant Drug Sales by Application (2019-2030)
  • 9.2.2 Asia Expectorant Drug Revenue by Application (2019-2030)
• 9.3 Asia Expectorant Drug Sales by Region
  • 9.3.1 Asia Expectorant Drug Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Expectorant Drug Revenue by Region (2019-2030)
  • 9.3.3 Asia Expectorant Drug Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Expectorant Drug Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Expectorant Drug Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Expectorant Drug Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Expectorant Drug Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Expectorant Drug Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Expectorant Drug Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Expectorant Drug Sales by Country
  • 10.3.1 Middle East, Africa and Latin America Expectorant Drug Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Expectorant Drug Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Expectorant Drug Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Abbott Laboratories Company Information
  • 11.1.2 Abbott Laboratories Overview
  • 11.1.3 Abbott Laboratories Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Abbott Laboratories Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Abbott Laboratories Recent Developments
• 11.2 Acella Pharmaceuticals LLC
  • 11.2.1 Acella Pharmaceuticals LLC Company Information
  • 11.2.2 Acella Pharmaceuticals LLC Overview
  • 11.2.3 Acella Pharmaceuticals LLC Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Acella Pharmaceuticals LLC Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Acella Pharmaceuticals LLC Recent Developments
• 11.3 Astrazeneca Plc.
  • 11.3.1 Astrazeneca Plc. Company Information
  • 11.3.2 Astrazeneca Plc. Overview
  • 11.3.3 Astrazeneca Plc. Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Astrazeneca Plc. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Astrazeneca Plc. Recent Developments
• 11.4 Cipla Limited
  • 11.4.1 Cipla Limited Company Information
  • 11.4.2 Cipla Limited Overview
  • 11.4.3 Cipla Limited Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Cipla Limited Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Cipla Limited Recent Developments
• 11.5 Dabur India Ltd
  • 11.5.1 Dabur India Ltd Company Information
  • 11.5.2 Dabur India Ltd Overview
  • 11.5.3 Dabur India Ltd Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Dabur India Ltd Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Dabur India Ltd Recent Developments
• 11.6 Glenmark Pharmaceuticals Limited
  • 11.6.1 Glenmark Pharmaceuticals Limited Company Information
  • 11.6.2 Glenmark Pharmaceuticals Limited Overview
  • 11.6.3 Glenmark Pharmaceuticals Limited Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Glenmark Pharmaceuticals Limited Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Glenmark Pharmaceuticals Limited Recent Developments
• 11.7 lohnson and Johnson
  • 11.7.1 lohnson and Johnson Company Information
  • 11.7.2 lohnson and Johnson Overview
  • 11.7.3 lohnson and Johnson Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 lohnson and Johnson Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 lohnson and Johnson Recent Developments
• 11.8 Merck KGaA
  • 11.8.1 Merck KGaA Company Information
  • 11.8.2 Merck KGaA Overview
  • 11.8.3 Merck KGaA Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 Merck KGaA Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Merck KGaA Recent Developments
• 11.9 Novartis International AG
  • 11.9.1 Novartis International AG Company Information
  • 11.9.2 Novartis International AG Overview
  • 11.9.3 Novartis International AG Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Novartis International AG Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Novartis International AG Recent Developments
• 11.10 Pfizer Inc.
  • 11.10.1 Pfizer Inc. Company Information
  • 11.10.2 Pfizer Inc. Overview
  • 11.10.3 Pfizer Inc. Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Pfizer Inc. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Pfizer Inc. Recent Developments
• 11.11 Proctor and Gamble Co
  • 11.11.1 Proctor and Gamble Co Company Information
  • 11.11.2 Proctor and Gamble Co Overview
  • 11.11.3 Proctor and Gamble Co Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Proctor and Gamble Co Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Proctor and Gamble Co Recent Developments
• 11.12 Reckitt Benckiser Group plc
  • 11.12.1 Reckitt Benckiser Group plc Company Information
  • 11.12.2 Reckitt Benckiser Group plc Overview
  • 11.12.3 Reckitt Benckiser Group plc Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Reckitt Benckiser Group plc Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Reckitt Benckiser Group plc Recent Developments
• 11.13 Sanofi SA
  • 11.13.1 Sanofi SA Company Information
  • 11.13.2 Sanofi SA Overview
  • 11.13.3 Sanofi SA Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.13.4 Sanofi SA Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Sanofi SA Recent Developments
• 11.14 The Himalaya Drug Company
  • 11.14.1 The Himalaya Drug Company Company Information
  • 11.14.2 The Himalaya Drug Company Overview
  • 11.14.3 The Himalaya Drug Company Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.14.4 The Himalaya Drug Company Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 The Himalaya Drug Company Recent Developments
• 11.15 Perrigo Company plc
  • 11.15.1 Perrigo Company plc Company Information
  • 11.15.2 Perrigo Company plc Overview
  • 11.15.3 Perrigo Company plc Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.15.4 Perrigo Company plc Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 Perrigo Company plc Recent Developments
• 11.16 Vernalis plc
  • 11.16.1 Vernalis plc Company Information
  • 11.16.2 Vernalis plc Overview
  • 11.16.3 Vernalis plc Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.16.4 Vernalis plc Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.16.5 Vernalis plc Recent Developments
• 11.17 Tris Pharma Inc.
  • 11.17.1 Tris Pharma Inc. Company Information
  • 11.17.2 Tris Pharma Inc. Overview
  • 11.17.3 Tris Pharma Inc. Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.17.4 Tris Pharma Inc. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.17.5 Tris Pharma Inc. Recent Developments
• 11.18 Aytu BioScience Inc.
  • 11.18.1 Aytu BioScience Inc. Company Information
  • 11.18.2 Aytu BioScience Inc. Overview
  • 11.18.3 Aytu BioScience Inc. Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.18.4 Aytu BioScience Inc. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.18.5 Aytu BioScience Inc. Recent Developments
• 11.19 Mayne Pharma Inc.
  • 11.19.1 Mayne Pharma Inc. Company Information
  • 11.19.2 Mayne Pharma Inc. Overview
  • 11.19.3 Mayne Pharma Inc. Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.19.4 Mayne Pharma Inc. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.19.5 Mayne Pharma Inc. Recent Developments
• 11.20 Taro Pharmaceutical Industries Ltd.
  • 11.20.1 Taro Pharmaceutical Industries Ltd. Company Information
  • 11.20.2 Taro Pharmaceutical Industries Ltd. Overview
  • 11.20.3 Taro Pharmaceutical Industries Ltd. Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.20.4 Taro Pharmaceutical Industries Ltd. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.20.5 Taro Pharmaceutical Industries Ltd. Recent Developments
• 11.21 Amneal Pharmaceuticals LLC
  • 11.21.1 Amneal Pharmaceuticals LLC Company Information
  • 11.21.2 Amneal Pharmaceuticals LLC Overview
  • 11.21.3 Amneal Pharmaceuticals LLC Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.21.4 Amneal Pharmaceuticals LLC Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.21.5 Amneal Pharmaceuticals LLC Recent Developments
• 11.22 Aurobindo Pharma Ltd
  • 11.22.1 Aurobindo Pharma Ltd Company Information
  • 11.22.2 Aurobindo Pharma Ltd Overview
  • 11.22.3 Aurobindo Pharma Ltd Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.22.4 Aurobindo Pharma Ltd Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.22.5 Aurobindo Pharma Ltd Recent Developments
• 11.23 GlaxoSmithKline plc.
  • 11.23.1 GlaxoSmithKline plc. Company Information
  • 11.23.2 GlaxoSmithKline plc. Overview
  • 11.23.3 GlaxoSmithKline plc. Expectorant Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.23.4 GlaxoSmithKline plc. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.23.5 GlaxoSmithKline plc. Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Expectorant Drug Industry Chain Analysis
• 12.2 Expectorant Drug Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Expectorant Drug Production Mode & Process
• 12.4 Expectorant Drug Sales and Marketing
  • 12.4.1 Expectorant Drug Sales Channels
  • 12.4.2 Expectorant Drug Distributors
• 12.5 Expectorant Drug Customers

13 Market Dynamics

• 13.1 Expectorant Drug Industry Trends
• 13.2 Expectorant Drug Market Drivers
• 13.3 Expectorant Drug Market Challenges
• 13.4 Expectorant Drug Market Restraints

14 Key Findings in The Global Expectorant Drug Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Expectorant Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
• Table 2. Major Manufacturers of Oral Solid
• Table 3. Major Manufacturers of Oral Liquid
• Table 4. Major Manufacturers of Inhalants
• Table 5. Global Expectorant Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
• Table 6. Global Expectorant Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
• Table 7. Global Expectorant Drug Revenue by Region (2019-2024) & (US$ Million)
• Table 8. Global Expectorant Drug Revenue by Region (2025-2030) & (US$ Million)
• Table 9. Global Expectorant Drug Revenue Market Share by Region (2019-2024)
• Table 10. Global Expectorant Drug Revenue Market Share by Region (2025-2030)
• Table 11. Global Expectorant Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
• Table 12. Global Expectorant Drug Sales by Region (2019-2024) & (K Units)
• Table 13. Global Expectorant Drug Sales by Region (2025-2030) & (K Units)
• Table 14. Global Expectorant Drug Sales Market Share by Region (2019-2024)
• Table 15. Global Expectorant Drug Sales Market Share by Region (2025-2030)
• Table 16. Global Expectorant Drug Sales by Manufacturers (2019-2024) & (K Units)
• Table 17. Global Expectorant Drug Sales Share by Manufacturers (2019-2024)
• Table 18. Global Expectorant Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
• Table 19. Global Expectorant Drug Revenue Share by Manufacturers (2019-2024)
• Table 20. Global Key Players of Expectorant Drug, Industry Ranking, 2022 VS 2023 VS 2024
• Table 21. Expectorant Drug Price by Manufacturers 2019-2024 (US$/Unit)
• Table 22. Global Expectorant Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 23. Global Expectorant Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Expectorant Drug as of 2023)
• Table 24. Global Key Manufacturers of Expectorant Drug, Manufacturing Base Distribution and Headquarters
• Table 25. Global Key Manufacturers of Expectorant Drug, Product Offered and Application
• Table 26. Global Key Manufacturers of Expectorant Drug, Date of Enter into This Industry
• Table 27. Mergers & Acquisitions, Expansion Plans
• Table 28. Global Expectorant Drug Sales by Type (2019-2024) & (K Units)
• Table 29. Global Expectorant Drug Sales by Type (2025-2030) & (K Units)
• Table 30. Global Expectorant Drug Sales Share by Type (2019-2024)
• Table 31. Global Expectorant Drug Sales Share by Type (2025-2030)
• Table 32. Global Expectorant Drug Revenue by Type (2019-2024) & (US$ Million)
• Table 33. Global Expectorant Drug Revenue by Type (2025-2030) & (US$ Million)
• Table 34. Global Expectorant Drug Revenue Share by Type (2019-2024)
• Table 35. Global Expectorant Drug Revenue Share by Type (2025-2030)
• Table 36. Expectorant Drug Price by Type (2019-2024) & (US$/Unit)
• Table 37. Global Expectorant Drug Price Forecast by Type (2025-2030) & (US$/Unit)
• Table 38. Global Expectorant Drug Sales by Application (2019-2024) & (K Units)
• Table 39. Global Expectorant Drug Sales by Application (2025-2030) & (K Units)
• Table 40. Global Expectorant Drug Sales Share by Application (2019-2024)
• Table 41. Global Expectorant Drug Sales Share by Application (2025-2030)
• Table 42. Global Expectorant Drug Revenue by Application (2019-2024) & (US$ Million)
• Table 43. Global Expectorant Drug Revenue by Application (2025-2030) & (US$ Million)
• Table 44. Global Expectorant Drug Revenue Share by Application (2019-2024)
• Table 45. Global Expectorant Drug Revenue Share by Application (2025-2030)
• Table 46. Expectorant Drug Price by Application (2019-2024) & (US$/Unit)
• Table 47. Global Expectorant Drug Price Forecast by Application (2025-2030) & (US$/Unit)
• Table 48. US & Canada Expectorant Drug Sales by Type (2019-2024) & (K Units)
• Table 49. US & Canada Expectorant Drug Sales by Type (2025-2030) & (K Units)
• Table 50. US & Canada Expectorant Drug Revenue by Type (2019-2024) & (US$ Million)
• Table 51. US & Canada Expectorant Drug Revenue by Type (2025-2030) & (US$ Million)
• Table 52. US & Canada Expectorant Drug Sales by Application (2019-2024) & (K Units)
• Table 53. US & Canada Expectorant Drug Sales by Application (2025-2030) & (K Units)
• Table 54. US & Canada Expectorant Drug Revenue by Application (2019-2024) & (US$ Million)
• Table 55. US & Canada Expectorant Drug Revenue by Application (2025-2030) & (US$ Million)
• Table 56. US & Canada Expectorant Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 57. US & Canada Expectorant Drug Revenue by Country (2019-2024) & (US$ Million)
• Table 58. US & Canada Expectorant Drug Revenue by Country (2025-2030) & (US$ Million)
• Table 59. US & Canada Expectorant Drug Sales by Country (2019-2024) & (K Units)
• Table 60. US & Canada Expectorant Drug Sales by Country (2025-2030) & (K Units)
• Table 61. Europe Expectorant Drug Sales by Type (2019-2024) & (K Units)
• Table 62. Europe Expectorant Drug Sales by Type (2025-2030) & (K Units)
• Table 63. Europe Expectorant Drug Revenue by Type (2019-2024) & (US$ Million)
• Table 64. Europe Expectorant Drug Revenue by Type (2025-2030) & (US$ Million)
• Table 65. Europe Expectorant Drug Sales by Application (2019-2024) & (K Units)
• Table 66. Europe Expectorant Drug Sales by Application (2025-2030) & (K Units)
• Table 67. Europe Expectorant Drug Revenue by Application (2019-2024) & (US$ Million)
• Table 68. Europe Expectorant Drug Revenue by Application (2025-2030) & (US$ Million)
• Table 69. Europe Expectorant Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 70. Europe Expectorant Drug Revenue by Country (2019-2024) & (US$ Million)
• Table 71. Europe Expectorant Drug Revenue by Country (2025-2030) & (US$ Million)
• Table 72. Europe Expectorant Drug Sales by Country (2019-2024) & (K Units)
• Table 73. Europe Expectorant Drug Sales by Country (2025-2030) & (K Units)
• Table 74. China Expectorant Drug Sales by Type (2019-2024) & (K Units)
• Table 75. China Expectorant Drug Sales by Type (2025-2030) & (K Units)
• Table 76. China Expectorant Drug Revenue by Type (2019-2024) & (US$ Million)
• Table 77. China Expectorant Drug Revenue by Type (2025-2030) & (US$ Million)
• Table 78. China Expectorant Drug Sales by Application (2019-2024) & (K Units)
• Table 79. China Expectorant Drug Sales by Application (2025-2030) & (K Units)
• Table 80. China Expectorant Drug Revenue by Application (2019-2024) & (US$ Million)
• Table 81. China Expectorant Drug Revenue by Application (2025-2030) & (US$ Million)
• Table 82. Asia Expectorant Drug Sales by Type (2019-2024) & (K Units)
• Table 83. Asia Expectorant Drug Sales by Type (2025-2030) & (K Units)
• Table 84. Asia Expectorant Drug Revenue by Type (2019-2024) & (US$ Million)
• Table 85. Asia Expectorant Drug Revenue by Type (2025-2030) & (US$ Million)
• Table 86. Asia Expectorant Drug Sales by Application (2019-2024) & (K Units)
• Table 87. Asia Expectorant Drug Sales by Application (2025-2030) & (K Units)
• Table 88. Asia Expectorant Drug Revenue by Application (2019-2024) & (US$ Million)
• Table 89. Asia Expectorant Drug Revenue by Application (2025-2030) & (US$ Million)
• Table 90. Asia Expectorant Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 91. Asia Expectorant Drug Revenue by Region (2019-2024) & (US$ Million)
• Table 92. Asia Expectorant Drug Revenue by Region (2025-2030) & (US$ Million)
• Table 93. Asia Expectorant Drug Sales by Region (2019-2024) & (K Units)
• Table 94. Asia Expectorant Drug Sales by Region (2025-2030) & (K Units)
• Table 95. Middle East, Africa and Latin America Expectorant Drug Sales by Type (2019-2024) & (K Units)
• Table 96. Middle East, Africa and Latin America Expectorant Drug Sales by Type (2025-2030) & (K Units)
• Table 97. Middle East, Africa and Latin America Expectorant Drug Revenue by Type (2019-2024) & (US$ Million)
• Table 98. Middle East, Africa and Latin America Expectorant Drug Revenue by Type (2025-2030) & (US$ Million)
• Table 99. Middle East, Africa and Latin America Expectorant Drug Sales by Application (2019-2024) & (K Units)
• Table 100. Middle East, Africa and Latin America Expectorant Drug Sales by Application (2025-2030) & (K Units)
• Table 101. Middle East, Africa and Latin America Expectorant Drug Revenue by Application (2019-2024) & (US$ Million)
• Table 102. Middle East, Africa and Latin America Expectorant Drug Revenue by Application (2025-2030) & (US$ Million)
• Table 103. Middle East, Africa and Latin America Expectorant Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 104. Middle East, Africa and Latin America Expectorant Drug Revenue by Country (2019-2024) & (US$ Million)
• Table 105. Middle East, Africa and Latin America Expectorant Drug Revenue by Country (2025-2030) & (US$ Million)
• Table 106. Middle East, Africa and Latin America Expectorant Drug Sales by Country (2019-2024) & (K Units)
• Table 107. Middle East, Africa and Latin America Expectorant Drug Sales by Country (2025-2030) & (K Units)
• Table 108. Abbott Laboratories Company Information
• Table 109. Abbott Laboratories Description and Major Businesses
• Table 110. Abbott Laboratories Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 111. Abbott Laboratories Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 112. Abbott Laboratories Recent Developments
• Table 113. Acella Pharmaceuticals LLC Company Information
• Table 114. Acella Pharmaceuticals LLC Description and Major Businesses
• Table 115. Acella Pharmaceuticals LLC Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 116. Acella Pharmaceuticals LLC Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 117. Acella Pharmaceuticals LLC Recent Developments
• Table 118. Astrazeneca Plc. Company Information
• Table 119. Astrazeneca Plc. Description and Major Businesses
• Table 120. Astrazeneca Plc. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 121. Astrazeneca Plc. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 122. Astrazeneca Plc. Recent Developments
• Table 123. Cipla Limited Company Information
• Table 124. Cipla Limited Description and Major Businesses
• Table 125. Cipla Limited Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 126. Cipla Limited Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 127. Cipla Limited Recent Developments
• Table 128. Dabur India Ltd Company Information
• Table 129. Dabur India Ltd Description and Major Businesses
• Table 130. Dabur India Ltd Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 131. Dabur India Ltd Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 132. Dabur India Ltd Recent Developments
• Table 133. Glenmark Pharmaceuticals Limited Company Information
• Table 134. Glenmark Pharmaceuticals Limited Description and Major Businesses
• Table 135. Glenmark Pharmaceuticals Limited Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 136. Glenmark Pharmaceuticals Limited Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 137. Glenmark Pharmaceuticals Limited Recent Developments
• Table 138. lohnson and Johnson Company Information
• Table 139. lohnson and Johnson Description and Major Businesses
• Table 140. lohnson and Johnson Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 141. lohnson and Johnson Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 142. lohnson and Johnson Recent Developments
• Table 143. Merck KGaA Company Information
• Table 144. Merck KGaA Description and Major Businesses
• Table 145. Merck KGaA Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 146. Merck KGaA Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 147. Merck KGaA Recent Developments
• Table 148. Novartis International AG Company Information
• Table 149. Novartis International AG Description and Major Businesses
• Table 150. Novartis International AG Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 151. Novartis International AG Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 152. Novartis International AG Recent Developments
• Table 153. Pfizer Inc. Company Information
• Table 154. Pfizer Inc. Description and Major Businesses
• Table 155. Pfizer Inc. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 156. Pfizer Inc. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 157. Pfizer Inc. Recent Developments
• Table 158. Proctor and Gamble Co Company Information
• Table 159. Proctor and Gamble Co Description and Major Businesses
• Table 160. Proctor and Gamble Co Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 161. Proctor and Gamble Co Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 162. Proctor and Gamble Co Recent Developments
• Table 163. Reckitt Benckiser Group plc Company Information
• Table 164. Reckitt Benckiser Group plc Description and Major Businesses
• Table 165. Reckitt Benckiser Group plc Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 166. Reckitt Benckiser Group plc Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 167. Reckitt Benckiser Group plc Recent Developments
• Table 168. Sanofi SA Company Information
• Table 169. Sanofi SA Description and Major Businesses
• Table 170. Sanofi SA Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 171. Sanofi SA Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 172. Sanofi SA Recent Developments
• Table 173. The Himalaya Drug Company Company Information
• Table 174. The Himalaya Drug Company Description and Major Businesses
• Table 175. The Himalaya Drug Company Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 176. The Himalaya Drug Company Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 177. The Himalaya Drug Company Recent Developments
• Table 178. Perrigo Company plc Company Information
• Table 179. Perrigo Company plc Description and Major Businesses
• Table 180. Perrigo Company plc Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 181. Perrigo Company plc Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 182. Perrigo Company plc Recent Developments
• Table 183. Vernalis plc Company Information
• Table 184. Vernalis plc Description and Major Businesses
• Table 185. Vernalis plc Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 186. Vernalis plc Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 187. Vernalis plc Recent Developments
• Table 188. Tris Pharma Inc. Company Information
• Table 189. Tris Pharma Inc. Description and Major Businesses
• Table 190. Tris Pharma Inc. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 191. Tris Pharma Inc. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 192. Tris Pharma Inc. Recent Developments
• Table 193. Aytu BioScience Inc. Company Information
• Table 194. Aytu BioScience Inc. Description and Major Businesses
• Table 195. Aytu BioScience Inc. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 196. Aytu BioScience Inc. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 197. Aytu BioScience Inc. Recent Developments
• Table 198. Mayne Pharma Inc. Company Information
• Table 199. Mayne Pharma Inc. Description and Major Businesses
• Table 200. Mayne Pharma Inc. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 201. Mayne Pharma Inc. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 202. Mayne Pharma Inc. Recent Developments
• Table 203. Taro Pharmaceutical Industries Ltd. Company Information
• Table 204. Taro Pharmaceutical Industries Ltd. Description and Major Businesses
• Table 205. Taro Pharmaceutical Industries Ltd. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 206. Taro Pharmaceutical Industries Ltd. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 207. Taro Pharmaceutical Industries Ltd. Recent Developments
• Table 208. Amneal Pharmaceuticals LLC Company Information
• Table 209. Amneal Pharmaceuticals LLC Description and Major Businesses
• Table 210. Amneal Pharmaceuticals LLC Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 211. Amneal Pharmaceuticals LLC Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 212. Amneal Pharmaceuticals LLC Recent Developments
• Table 213. Aurobindo Pharma Ltd Company Information
• Table 214. Aurobindo Pharma Ltd Description and Major Businesses
• Table 215. Aurobindo Pharma Ltd Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 216. Aurobindo Pharma Ltd Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 217. Aurobindo Pharma Ltd Recent Developments
• Table 218. GlaxoSmithKline plc. Company Information
• Table 219. GlaxoSmithKline plc. Description and Major Businesses
• Table 220. GlaxoSmithKline plc. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 221. GlaxoSmithKline plc. Expectorant Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 222. GlaxoSmithKline plc. Recent Developments
• Table 223. Key Raw Materials Lists
• Table 224. Raw Materials Key Suppliers Lists
• Table 225. Expectorant Drug Distributors List
• Table 226. Expectorant Drug Customers List
• Table 227. Expectorant Drug Market Trends
• Table 228. Expectorant Drug Market Drivers
• Table 229. Expectorant Drug Market Challenges
• Table 230. Expectorant Drug Market Restraints
• Table 231. Research Programs/Design for This Report
• Table 232. Key Data Information from Secondary Sources
• Table 233. Key Data Information from Primary Sources

List of Figures

• Figure 1. Expectorant Drug Product Picture
• Figure 2. Global Expectorant Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
• Figure 3. Global Expectorant Drug Market Share by Type in 2023 & 2030
• Figure 4. Oral Solid Product Picture
• Figure 5. Oral Liquid Product Picture
• Figure 6. Inhalants Product Picture
• Figure 7. Global Expectorant Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
• Figure 8. Global Expectorant Drug Market Share by Application in 2023 & 2030
• Figure 9. Hospital
• Figure 10. Clinic
• Figure 11. Other
• Figure 12. Expectorant Drug Report Years Considered
• Figure 13. Global Expectorant Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
• Figure 14. Global Expectorant Drug Revenue 2019-2030 (US$ Million)
• Figure 15. Global Expectorant Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
• Figure 16. Global Expectorant Drug Revenue Market Share by Region (2019-2030)
• Figure 17. Global Expectorant Drug Sales 2019-2030 ((K Units)
• Figure 18. Global Expectorant Drug Sales Market Share by Region (2019-2030)
• Figure 19. US & Canada Expectorant Drug Sales YoY (2019-2030) & (K Units)
• Figure 20. US & Canada Expectorant Drug Revenue YoY (2019-2030) & (US$ Million)
• Figure 21. Europe Expectorant Drug Sales YoY (2019-2030) & (K Units)
• Figure 22. Europe Expectorant Drug Revenue YoY (2019-2030) & (US$ Million)
• Figure 23. China Expectorant Drug Sales YoY (2019-2030) & (K Units)
• Figure 24. China Expectorant Drug Revenue YoY (2019-2030) & (US$ Million)
• Figure 25. Asia (excluding China) Expectorant Drug Sales YoY (2019-2030) & (K Units)
• Figure 26. Asia (excluding China) Expectorant Drug Revenue YoY (2019-2030) & (US$ Million)
• Figure 27. Middle East, Africa and Latin America Expectorant Drug Sales YoY (2019-2030) & (K Units)
• Figure 28. Middle East, Africa and Latin America Expectorant Drug Revenue YoY (2019-2030) & (US$ Million)
• Figure 29. The Expectorant Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
• Figure 30. The Top 5 and 10 Largest Manufacturers of Expectorant Drug in the World: Market Share by Expectorant Drug Revenue in 2023
• Figure 31. Global Expectorant Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
• Figure 32. Global Expectorant Drug Sales Market Share by Type (2019-2030)
• Figure 33. Global Expectorant Drug Revenue Market Share by Type (2019-2030)
• Figure 34. Global Expectorant Drug Sales Market Share by Application (2019-2030)
• Figure 35. Global Expectorant Drug Revenue Market Share by Application (2019-2030)
• Figure 36. US & Canada Expectorant Drug Sales Market Share by Type (2019-2030)
• Figure 37. US & Canada Expectorant Drug Revenue Market Share by Type (2019-2030)
• Figure 38. US & Canada Expectorant Drug Sales Market Share by Application (2019-2030)
• Figure 39. US & Canada Expectorant Drug Revenue Market Share by Application (2019-2030)
• Figure 40. US & Canada Expectorant Drug Revenue Share by Country (2019-2030)
• Figure 41. US & Canada Expectorant Drug Sales Share by Country (2019-2030)
• Figure 42. U.S. Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 43. Canada Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 44. Europe Expectorant Drug Sales Market Share by Type (2019-2030)
• Figure 45. Europe Expectorant Drug Revenue Market Share by Type (2019-2030)
• Figure 46. Europe Expectorant Drug Sales Market Share by Application (2019-2030)
• Figure 47. Europe Expectorant Drug Revenue Market Share by Application (2019-2030)
• Figure 48. Europe Expectorant Drug Revenue Share by Country (2019-2030)
• Figure 49. Europe Expectorant Drug Sales Share by Country (2019-2030)
• Figure 50. Germany Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 51. France Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 52. U.K. Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 53. Italy Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 54. Netherlands Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 55. China Expectorant Drug Sales Market Share by Type (2019-2030)
• Figure 56. China Expectorant Drug Revenue Market Share by Type (2019-2030)
• Figure 57. China Expectorant Drug Sales Market Share by Application (2019-2030)
• Figure 58. China Expectorant Drug Revenue Market Share by Application (2019-2030)
• Figure 59. Asia Expectorant Drug Sales Market Share by Type (2019-2030)
• Figure 60. Asia Expectorant Drug Revenue Market Share by Type (2019-2030)
• Figure 61. Asia Expectorant Drug Sales Market Share by Application (2019-2030)
• Figure 62. Asia Expectorant Drug Revenue Market Share by Application (2019-2030)
• Figure 63. Asia Expectorant Drug Revenue Share by Region (2019-2030)
• Figure 64. Asia Expectorant Drug Sales Share by Region (2019-2030)
• Figure 65. Japan Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 66. South Korea Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 67. China Taiwan Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 68. Southeast Asia Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 69. India Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 70. Middle East, Africa and Latin America Expectorant Drug Sales Market Share by Type (2019-2030)
• Figure 71. Middle East, Africa and Latin America Expectorant Drug Revenue Market Share by Type (2019-2030)
• Figure 72. Middle East, Africa and Latin America Expectorant Drug Sales Market Share by Application (2019-2030)
• Figure 73. Middle East, Africa and Latin America Expectorant Drug Revenue Market Share by Application (2019-2030)
• Figure 74. Middle East, Africa and Latin America Expectorant Drug Revenue Share by Country (2019-2030)
• Figure 75. Middle East, Africa and Latin America Expectorant Drug Sales Share by Country (2019-2030)
• Figure 76. Brazil Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 77. Mexico Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 78. Turkey Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 79. Israel Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 80. GCC Countries Expectorant Drug Revenue (2019-2030) & (US$ Million)
• Figure 81. Expectorant Drug Value Chain
• Figure 82. Expectorant Drug Production Process
• Figure 83. Channels of Distribution
• Figure 84. Distributors Profiles
• Figure 85. Bottom-up and Top-down Approaches for This Report
• Figure 86. Data Triangulation
• Figure 87. Key Executives Interviewed